ID: ALA3818540

Max Phase: Preclinical

Molecular Formula: C32H32ClN5O3

Molecular Weight: 570.09

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCCCc1nc(Cl)c(/C=N/N2C(=O)c3cccc4c(N5CCOCC5)ccc(c34)C2=O)n1Cc1ccc(C)cc1

Standard InChI:  InChI=1S/C32H32ClN5O3/c1-3-4-8-28-35-30(33)27(37(28)20-22-11-9-21(2)10-12-22)19-34-38-31(39)24-7-5-6-23-26(36-15-17-41-18-16-36)14-13-25(29(23)24)32(38)40/h5-7,9-14,19H,3-4,8,15-18,20H2,1-2H3/b34-19+

Standard InChI Key:  WKSBXAFZBSWMLU-ALQBTCKLSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 570.09

Molecular Weight (Monoisotopic): 569.2194

AlogP: 5.86

#Rotatable Bonds: 8

Polar Surface Area: 80.03

Molecular Species: NEUTRAL

HBA: 7

HBD: 0

#RO5 Violations: 2

HBA (Lipinski): 8

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 2

CX Acidic pKa:

CX Basic pKa: 3.47

CX LogP: 6.51

CX LogD: 6.51

Aromatic Rings: 4

Heavy Atoms: 41

QED Weighted: 0.20

Np Likeness Score: -1.23

References

1. Gong H, Baathulaa K, Lv J, Cai G, Zhou C.  (2016)  Synthesis and biological evaluation of Schiff base-linked imidazolyl naphthalimides as novel potential anti-MRSA agents,  7  (5): [10.1039/C5MD00574D]

Source

Source(1):

• Scientific Literature